FI952458L - Dimetyylibentsofuraanien ja dimetyylibentsopyraanien käyttö 5-HT3-antagonisteina - Google Patents

Dimetyylibentsofuraanien ja dimetyylibentsopyraanien käyttö 5-HT3-antagonisteina Download PDF

Info

Publication number
FI952458L
FI952458L FI952458A FI952458A FI952458L FI 952458 L FI952458 L FI 952458L FI 952458 A FI952458 A FI 952458A FI 952458 A FI952458 A FI 952458A FI 952458 L FI952458 L FI 952458L
Authority
FI
Finland
Prior art keywords
dimethylbenzopyrans
dimethylbenzofurans
antagonists
Prior art date
Application number
FI952458A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI952458A0 (fi
FI952458A7 (fi
Inventor
Daele Georges Henri Paul Van
Jean-Paul Rene Marie A Bosmans
Laerhoven Willy Joannes Ca Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI952458A0 publication Critical patent/FI952458A0/fi
Publication of FI952458A7 publication Critical patent/FI952458A7/fi
Publication of FI952458L publication Critical patent/FI952458L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Otolaryngology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Dental Preparations (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI952458A 1992-11-20 1993-11-15 Dimetyylibentsofuraanien ja dimetyylibentsopyraanien käyttö 5-HT3-antagonisteina FI952458L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97901392A 1992-11-20 1992-11-20
PCT/EP1993/003206 WO1994012494A1 (en) 1992-11-20 1993-11-15 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists

Publications (3)

Publication Number Publication Date
FI952458A0 FI952458A0 (fi) 1995-05-19
FI952458A7 FI952458A7 (fi) 1995-05-19
FI952458L true FI952458L (fi) 1995-05-19

Family

ID=25526607

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952458A FI952458L (fi) 1992-11-20 1993-11-15 Dimetyylibentsofuraanien ja dimetyylibentsopyraanien käyttö 5-HT3-antagonisteina

Country Status (31)

Country Link
US (2) US5674868A (enExample)
EP (1) EP0669919B1 (enExample)
JP (1) JP2830952B2 (enExample)
KR (1) KR0166661B1 (enExample)
AT (1) ATE176232T1 (enExample)
AU (1) AU680640B2 (enExample)
BG (1) BG62489B1 (enExample)
BR (1) BR9307477A (enExample)
CA (1) CA2149044C (enExample)
CZ (1) CZ287262B6 (enExample)
DE (1) DE69323322T2 (enExample)
DK (1) DK0669919T3 (enExample)
ES (1) ES2129615T3 (enExample)
FI (1) FI952458L (enExample)
GR (1) GR3029831T3 (enExample)
HU (2) HUT72740A (enExample)
IL (3) IL119273A0 (enExample)
LV (1) LV10956B (enExample)
MX (1) MX9307257A (enExample)
NO (2) NO307690B1 (enExample)
NZ (1) NZ257854A (enExample)
OA (1) OA10158A (enExample)
PL (1) PL176051B1 (enExample)
RO (1) RO115160B1 (enExample)
RU (1) RU2116072C1 (enExample)
SG (1) SG47488A1 (enExample)
SK (1) SK282378B6 (enExample)
TW (1) TW294595B (enExample)
UA (1) UA49792C2 (enExample)
WO (1) WO1994012494A1 (enExample)
ZA (1) ZA938676B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
AU745361B2 (en) 1997-04-18 2002-03-21 Janssen Pharmaceutica N.V. Use of 5HT3 antagonists for promoting intestinal lavage
HUP0003078A3 (en) * 1997-07-11 2002-02-28 Janssen Pharmaceutica Nv (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
US6239122B1 (en) * 2000-01-05 2001-05-29 Joy Ann Steele Method of treatment of nausea, vomiting, and other disorders using estrogens
ATE440825T1 (de) * 2003-06-06 2009-09-15 Vertex Pharma Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern
NZ546990A (en) 2003-11-20 2010-03-26 Janssen Pharmaceutica Nv 7-Phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors
NZ546991A (en) 2003-11-20 2010-01-29 Janssen Pharmaceutica Nv 6-Alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as PARP inhibitors
CA2568835C (en) * 2004-06-30 2014-05-27 Janssen Pharmaceutica N.V. Quinazolinone derivatives as parp inhibitors
WO2006003147A1 (en) 2004-06-30 2006-01-12 Janssen Pharmaceutica N.V. Phthalazine derivatives as parp inhibitors
JP5100376B2 (ja) 2004-06-30 2012-12-19 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Parp阻害剤としてのキナゾリンジオン誘導体
JP5545955B2 (ja) 2007-03-08 2014-07-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Parpおよびtank阻害剤としてのキノリノン誘導体
WO2009053373A1 (en) 2007-10-26 2009-04-30 Janssen Pharmaceutica Nv Quinolinone derivatives as parp inhibitors
WO2009118384A1 (en) 2008-03-27 2009-10-01 Janssen Pharmaceutica Nv Quinazolinone derivatives as tubulin polymerization inhibitors
DK2271626T3 (en) 2008-03-27 2015-02-23 Janssen Pharmaceutica Nv TETRAHYDROPHENANTHRIDINONES AND TETRAHYDROCYCLOPENTAQUINOLINONES AS INHIBITORS OF POLYMERIZATION OF PARP AND TUBULIN

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
ZW12187A1 (en) * 1986-07-03 1989-02-01 Janssen Pharmaceutica Nv 4-(aroylamino)piperidinebutanamide derivatives
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
US4914207A (en) * 1989-05-09 1990-04-03 Pfizer Inc. Arylthiazolylimidazoles
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives

Also Published As

Publication number Publication date
SG47488A1 (en) 1998-04-17
PL176051B1 (pl) 1999-03-31
TW294595B (enExample) 1997-01-01
JP2830952B2 (ja) 1998-12-02
AU680640B2 (en) 1997-08-07
PL309045A1 (en) 1995-09-18
NZ257854A (en) 1997-04-24
IL107654A (en) 1998-01-04
DK0669919T3 (da) 1999-09-13
HU211546A9 (en) 1995-12-28
AU5465994A (en) 1994-06-22
BG62489B1 (bg) 1999-12-30
NO995762L (no) 1995-05-19
ZA938676B (en) 1995-05-19
GR3029831T3 (en) 1999-06-30
LV10956A (lv) 1995-12-20
FI952458A0 (fi) 1995-05-19
CZ287262B6 (en) 2000-10-11
SK282378B6 (sk) 2002-01-07
UA49792C2 (uk) 2002-10-15
JPH08505840A (ja) 1996-06-25
BR9307477A (pt) 1999-06-29
FI952458A7 (fi) 1995-05-19
EP0669919B1 (en) 1999-01-27
IL119273A (en) 2000-07-16
US5863923A (en) 1999-01-26
DE69323322D1 (de) 1999-03-11
ES2129615T3 (es) 1999-06-16
OA10158A (en) 1996-12-18
IL107654A0 (en) 1994-02-27
RU2116072C1 (ru) 1998-07-27
NO951980D0 (no) 1995-05-19
HUT72740A (en) 1996-05-28
KR0166661B1 (ko) 1999-01-15
IL119273A0 (en) 1996-12-05
MX9307257A (es) 1994-05-31
EP0669919A1 (en) 1995-09-06
DE69323322T2 (de) 1999-09-09
BG99593A (en) 1995-12-29
SK67595A3 (en) 1995-11-08
NO308530B1 (no) 2000-09-25
RU95113434A (ru) 1997-03-10
NO307690B1 (no) 2000-05-15
CA2149044A1 (en) 1994-06-09
WO1994012494A1 (en) 1994-06-09
CZ125895A3 (en) 1995-10-18
CA2149044C (en) 2007-04-03
HU9501476D0 (en) 1995-07-28
NO995762D0 (no) 1999-11-24
LV10956B (en) 1996-10-20
NO951980L (no) 1995-05-19
ATE176232T1 (de) 1999-02-15
RO115160B1 (ro) 1999-11-30
US5674868A (en) 1997-10-07

Similar Documents

Publication Publication Date Title
FI953666L (fi) Hetersykliset yhdisteet ja niiden valmistus ja käyttö
FI954131A7 (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FI945625A7 (fi) Indolokarbatsoli-imidit ja niiden käyttö
FI945434L (fi) 4-markatpoasetyyliamino/2/bentsatsepinoni (3) johdannaisia ja niiden käyttö enkefalinaasi-inhibiittoreina
FI19992420L (fi) Mikrobifytaasin kloonaus ja ilmentäminen
FI954130L (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FI904659A7 (fi) Uusia bentsimidatsoliyhdisteitä ja niiden käyttö
FI955430A7 (fi) Bisyklisiä amidijohdannaisia ja niiden käyttö lihasten jännitystä lauk aisevina aineena
FI960353A0 (fi) Ihmisen interleukiini-10:n agonistit ja antagonistit
FI943313A7 (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FI935728L (fi) Substituoituja 4-fenyylipyridoneja ja 4-fenyyli-2-alkoksipyridiinejä
FI952458A7 (fi) Dimetyylibentsofuraanien ja dimetyylibentsopyraanien käyttö 5-HT3-anta gonisteina
FI943837L (fi) Ksylanaasi B:n kloonaus ja ilmentäminen
FI922905A7 (fi) Imidatsoliyhdisteiden valmistus ja käyttö
FI951992A7 (fi) Uusia substituoituja atsetidinoneja anti-inflammatorisina ja antidegeneratiivisina aineina
FI945427A7 (fi) Dynemisiinianalogien enantiomeerit, niiden valmistus ja käyttö
NO940190D0 (no) Anvendelse av x-ketoglutarat
FI944714A7 (fi) Beta-karboliinien uusi käyttö
NO931399D0 (no) Anvendelse av naturstein
FI950883L (fi) BAPP-C100-reseptorin kloonaus ja ilmentäminen
FI950515A7 (fi) Isoseriinijohdannaiset ja niiden käyttö leukotrieeniantagonisteina
FI922124A7 (fi) Atsabisykloamideja ja estereitä 5-HT3-reseptorin antagonisteina
FI974609A7 (fi) Uusia heterosyklisiä yhdisteitä kivun hoitoon ja niiden käyttö
IS4109A (is) Notkun handhverfs díhýdrópýridíns
KR920021881U (ko) 최루분사용